Renovia, a digital therapeutics maker for female pelvic floor disorders, today shared the closing of its Series C-1 financing round worth $17 million.
The round included previous backers including Perceptive Life Sciences, Longwood Fund, Ascension Ventures and OSF Ventures, in addition to new investor Parian Global Management.
WHAT THEY DO
Renovia's flagship product, leva, is an FDA-cleared...
Grenoble-based developer and manufacturer of the electronic artificial urinary sphincter (eAUS), UroMems has raised an additional €7 million in the second round of its Series B financing which was completed in May 2020.
The additional investment was provided by existing investors including Hil-Invent GmbH, Financière Arbevel, Wellington Partners, Bpifrance, via its FABS fund, Supernova Invest and...
San Diego-based Triple W has launched a new wearable connected health monitor in the United States, focused on urinary incontinence. The sensor, called DFree, uses an ultrasound sensor to monitor changes in bladder size. Then proprietary algorithms translate that data into information about when a user should head to the bathroom.
“DFree is designed to help individuals with incontinence improve...
